who should take a glp 1 Long-term Success of GLP-1s Hinges on More Than Just Prescription What are GLP-1s? | Mendinground

In the process of exploring the relationship between GLP-1RAs and SA, we cannot afford to overlook the remarkable effects of GLP-1RAs in other important areas of health, particularly in cardiovascular disease (CVD)

This data offers meaningful proof that a structured, clinically integrated GLP-1 strategy can deliver millions in real savings without compromising access or member outcomes.* Employer health strategies have traditionally centered on condition-specific programs to manage diseases like obesity, diabetes, and cardiovascular conditions individually, which has led to employers managing multiple point solutions simultaneously, often with low coordination, engagement, and return on investment

They are only legally sold and distributed for research purposes

Independent of hemodynamic effects, from a metabolic perspective, SGLT2 inhibitors promote glucosuria and modestly improve glycemic control [15,16]